Objective: To estimate the prevalence of and associated factors in gestational diabetes mellitus (GDM) and its seasonal variation.
Study Design: A clinic-based, prospective, case register study was conducted from January 1996 to December 1997. A total of 4,942 consecutive Caucasian, pregnant women aged 15-46 years,free of a history of diabetes mellitus, underwent random plasma glucose screening and a 75-g, 2-hour oral glucose tolerance test in Plymouth, U.K. The mean (SD) age of the women was 28.2 (5.5) years. Women with and without GDM were compared.
Results: The prevalence of GDM among the subjects was 1.8% (95% CI 1.4,2.2). The prevalence of GDM increased with the mother's age and random plasma glucose level and decreased with the duration of pregnancy. Using a stepwise binary logistic regression model, older age (relative prevalence [RP] 1.08 [95% CI 1.04, 1.12]) and higher random plasma glucose (RP 2.99 [95% CI 2.51, 3.551) were significant predictors of GDM. The monthly prevalence of GDM ranged from 2.9% (95% CI 1.5, 5.0) in June to 1.1% (95% CI 0.3,2.8) in November. The seasonal GDM rate ranged from 2.3% (95% CI 1.5, 3.2) in spring to 1.4% (95% CI 0.8, 2.3) in winter. The differences were not statistically significant for either the month (p = 0.82) or season (p = 0.41).
Conclusion: The prevalence (1.8%) of GDM in this representative sample of Caucasian pregnant women was lower than the 3-5% typically reported in other European and North American studies, and there was no seasonal pattern.
Download full-text PDF |
Source |
---|
BMC Oral Health
January 2025
Innovation Center of Nursing Research, Nursing Key Laboratory of Sichuan Province, West China Hospital, Sichuan University, No.37, Guoxue Lane, Wuhou District, Chengdu, China.
Background: Diabetes with its highly prevalence has become a major contributor to the burden of health care costs worldwide. Recent unequivocal evidence has revealed a bidirectional link between oral health and diabetes. In this study, the effects of the Oral Health Promotion Program (OHPP) on oral hygiene, oral health-related quality of life and glycated haemoglobin (HbA1c) levels in diabetic elderly were examined.
View Article and Find Full Text PDFBMC Pregnancy Childbirth
January 2025
Department of Medical Laboratory Sciences, College of Medicine and Health Sciences, Bahir Dar University, Bahir Dar, Ethiopia.
Background: Vaginal colonization by Candida can lead to vulvovaginal candidiasis, which is the second most prevalent vaginal condition globally. It is frequently associated with sepsis and adverse neonatal outcomes in pregnant women. This issue is worsening in Sub-Saharan Africa, including Ethiopia.
View Article and Find Full Text PDFSci Rep
January 2025
Department of Gastroenterology, Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University, Changzhou Medical Center, Nanjing Medical University, 68 Gehu Middle Road, Wujing District, Changzhou, 213000, Jiangsu, China.
Patients with diabetes have a high risk of failure of H. pylori eradication therapy. The present study aims to evaluate the efficacy and safety of vonoprazan-amoxicillin (VA) dual therapy for the treatment of H.
View Article and Find Full Text PDFSci Rep
January 2025
Faculty of Pharmacy, Department of Pharmacology and Toxicology, Comenius University Bratislava, SK-83232, Bratislava, Slovakia.
Oxidative stress and apoptosis are highly engaged in development of diabetic nephropathy (DN). In monotherapy, dapagliflozin and pioglitazone positively modulate target organ damage even independently of their hypoglycaemic effect. This study evaluated whether a simultaneous PPARγ activation and SGLT cotransporter inhibition offer superior protection against DN-related oxidative and apoptotic processes in a T1DM rat model.
View Article and Find Full Text PDFSci Rep
January 2025
Endocrinology and Metabolism Research Center (EMRC), School of Medicine, Vali-Asr Hospital, Tehran University of Medical Sciences, P.O. Box: 13145-784, Tehran, Iran.
The management of Type-2 Diabetes Mellitus (T2DM) remains challenging in cases of poor glycemic control despite triple Oral Hypoglycemic Agent (OHA) therapy. This prospective cohort study aimed to assess the effectiveness of Empagliflozin as part of a quadruple OHA regimen over a 7-year follow-up period in 575 adult patients with uncontrolled T2DM on a triple OHA regimen and who were unwilling to initiate insulin therapy. Overall, 92.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!